| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2021―Sep―13 |
Identification of homologous human miRNAs as antivirals towards COVID-19 genome |
Jitender Singh, Ashvinder Raina, Namrata Sangwan, Arushi Chauhan, K. L. Khanduja, Pramod K. Avti |
| 2 |
[GO] |
2021―Feb―13 |
An in-silico analysis of effective siRNAs against COVID-19 by targeting the leader sequence of SARS-CoV-2 |
Anand Kumar Pandey, Shalja Verma |
| 3 |
[GO] |
2020―Jul―12 |
Rapid production of clinical-grade SARS-CoV-2 specific T cells |
Wing Leung, Teck Guan Soh, Yeh Ching Linn, Jenny Guek-Hong Low, Jiashen Loh, Marieta Chan, et al. (+8) Wee Joo Chng, Liang Piu Koh, Michelle Li-Mei Poon, King Pan Ng, Chik Hong Kuick, Thuan Tong Tan, Lip Kun Tan, Michaela Su-fern Seng |
| 4 |
[GO] |
2020―Jun―01 |
COVID-19 & Allogeneic Transplant: Activity and Preventive Measures for Best Outcomes in China |
Zheng-Li Xu, Xiao-Jun Huang |
| 5 |
[GO] |
2020―May―11 |
Perspective: Cell therapy, SARS-CoV-2 , COVID-19 and James Lind |
Robert Peter Gale |
|
